Loading clinical trials...
Loading clinical trials...
Microembolization is commonly associated with carotid artery stenting (CAS), but our understanding of subclinical microembolization is superficial. Through collaborative effects of multidisciplinary team-experts, novel approaches, and longitudinal evaluations, we hope to better understand the clinical significance and long-term cognitive effects of microemboli. This proposal may change our current clinical practice by providing a better outcome measure for carotid interventions and improving outcomes of CAS procedures through risk factor stratification. Our central hypothesis is that development of subclinical microemboli is associated with decline in cognitive function following CAS and that the risk of development of microemboli themselves is associated with patient- and procedure-related factors. We hope that this prospective study will help to clarify these important issues in the era of rapidly evolving percutaneous interventions.
Age
40 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Palo Alto Veterans Affairs
Palo Alto, California, United States
Washington University School of Medicine
St Louis, Missouri, United States
University of Wisconsin, Madison
Madison, Wisconsin, United States
Start Date
June 1, 2011
Primary Completion Date
April 1, 2018
Completion Date
April 1, 2018
Last Updated
August 29, 2022
207
ACTUAL participants
Neuropsychological testing
BEHAVIORAL
Lead Sponsor
Stanford University
Collaborators
NCT06936189
NCT06936176
NCT06541691
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions